Difference between revisions of "Berberine"
| Line 16: | Line 16: | ||
[http://www.alstdi.org/forum/yaf_postst48627_berberine.aspx Berberine] | [http://www.alstdi.org/forum/yaf_postst48627_berberine.aspx Berberine] | ||
| + | |||
| + | |||
| + | == References == | ||
| + | |||
| + | [1] | ||
| + | <bibtex> | ||
| + | @article{Lin2013, | ||
| + | author = {Lin, Tzu-Yu and Lin, Yu-Wan and Lu, Cheng-Wei and Huang, Shu-Kuei and Wang, Su-Jane}, | ||
| + | doi = {10.1371/journal.pone.0067215}, | ||
| + | editor = {Woodhall, Gavin}, | ||
| + | file = {:C$\backslash$:/Users/riku/AppData/Local/Mendeley Ltd./Mendeley Desktop/Downloaded/Lin et al. - 2013 - Berberine Inhibits the Release of Glutamate in Nerve Terminals from Rat Cerebral Cortex.pdf:pdf}, | ||
| + | issn = {1932-6203}, | ||
| + | journal = {PLoS ONE}, | ||
| + | mendeley-groups = {berberine}, | ||
| + | month = jun, | ||
| + | number = {6}, | ||
| + | pages = {e67215}, | ||
| + | publisher = {Public Library of Science}, | ||
| + | title = {{Berberine Inhibits the Release of Glutamate in Nerve Terminals from Rat Cerebral Cortex}}, | ||
| + | url = {http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0067215}, | ||
| + | volume = {8}, | ||
| + | year = {2013} | ||
| + | } | ||
| + | </bibtex> | ||
Revision as of 20:02, 30 September 2015
Information on nutritional supplements people with ALS have been taking
examine.com summarizes:
- Berberine is an alkaloid extracted from various plants used in Traditional Chinese Medicine.
- Berberine is supplemented for its anti-inflammatory and anti-diabetic effects. It can also improve intestinal health and lower cholesterol. Berberine is able to reduce glucose production in the liver. Human and animal research demonstrates that 1500mg of berberine, taken in three doses of 500mg each, is equally effective as taking 1500mg of metformin or 4mg glibenclamide, two pharmaceuticals for treating type II diabetes. Effectiveness was measured by how well the drugs reduced biomarkers of type II diabetes.
- Berberine may also synergize with anti-depressant medication and help with body fat loss. Both of these benefits need additional evidence behind them before berberine can be recommended specifically for these reasons.
- Berberine’s main mechanism is partly responsible for its anti-diabetic and anti-inflammatory effects. Berberine is able to activate an enzyme called Adenosine Monophosphate-Activated Protein Kinase (AMPK) while inhibiting Protein-Tyrosine Phosphatase 1B (PTP1B).
Discussion threads on the ALSTDI forum
References
[1] <bibtex> @article{Lin2013, author = {Lin, Tzu-Yu and Lin, Yu-Wan and Lu, Cheng-Wei and Huang, Shu-Kuei and Wang, Su-Jane}, doi = {10.1371/journal.pone.0067215}, editor = {Woodhall, Gavin}, file = {:C$\backslash$:/Users/riku/AppData/Local/Mendeley Ltd./Mendeley Desktop/Downloaded/Lin et al. - 2013 - Berberine Inhibits the Release of Glutamate in Nerve Terminals from Rat Cerebral Cortex.pdf:pdf}, issn = {1932-6203}, journal = {PLoS ONE}, mendeley-groups = {berberine}, month = jun, number = {6}, pages = {e67215}, publisher = {Public Library of Science}, title = Template:Berberine Inhibits the Release of Glutamate in Nerve Terminals from Rat Cerebral Cortex, url = {http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0067215}, volume = {8}, year = {2013} } </bibtex>
